DUMAC Inc’s Hims & Hers Health HIMS Stock Holding History

DUMAC Inc’s Portfolio HIMS Stock Details HIMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-598,911	Closed	-$4.52M	–	30
2021 Q3	$4.52M	Buy	+598,911	New	+$5.07M	7.74%	4

Other funds holding HIMS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redpoint Management Woodside, California $201M AUM 39.14% 1-Year Est. Return

Institutional Venture Management XV Menlo Park, California $75.5M AUM 16.43% 1-Year Est. Return

Institutional Venture Management XVI Menlo Park, California $1.18M AUM 156.01% 1-Year Est. Return

Forerunner Ventures Management San Francisco, California $169M AUM

NewView Capital Partners I Burlingame, California $28M AUM 10.55% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Disruptive Technology Advisers Austin, Texas $724K AUM 65.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

DUMAC Inc's HIMS Position: Q4 2021 in Review

DUMAC Inc sold out of Hims & Hers Health (HIMS) in Q4 2021, closing a stake of 598,911 shares — an estimated $4.52M sold.

DUMAC Inc first reported a position in HIMS in Q3 2021 and held it in 1 quarter. The position peaked at $4.52M in Q3 2021. 141 funds tracked by Wall St. Rank hold HIMS as of Q4 2021.

DUMAC Inc reported no remaining Hims & Hers Health position as of Q4 2021 after selling out during the quarter.
DUMAC Inc sold 598,911 Hims & Hers Health shares in Q4 2021, an estimated $4.52M.
DUMAC Inc first reported a position in Hims & Hers Health in Q3 2021 and held it in 1 quarter.
DUMAC Inc's Hims & Hers Health position peaked at $4.52M in Q3 2021.
141 funds tracked by Wall St. Rank held Hims & Hers Health as of Q4 2021.

Based on DUMAC Inc's 13F filing for Q4 2021, filed 14 Feb 2022.